“The rating reflects our view of KHN’s improved operational performance and strengthened balance sheet over the past three years, with healthy operating margins, robust maximum annual debt service coverage and growth in unrestricted reserves, all of which are consistent with the higher rating level,” said S&P analyst Avani Parikh.
The system’s outlook is stable, which reflects S&P’s expectation that over the two-year outlook period KHN will sustain healthy operating trends while improving its balance sheet metrics.
More articles on healthcare finance:
4 Louisiana safety-net hospitals at risk of closure
Major health systems, payers make progress toward value-based payment goal
South Dakota hospital set to lose Medicare status
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
